azacitidine,venetoclax
abbvie,roche
['venetoclax', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)', 'azacitidine,(-oral azaci),(-azacitidine oral)', 'aza ', '+aza', 'leusm']
#ash22 #leusm d hner: survival outcomes clearly different in higher benefit group, less evident in int, and no diff in lower. nb: this model only included non-allo eligible pts. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)